Study of Chemotherapy With or Without Pembrolizumab Followed by Maintenance With Olaparib or Placebo for the First-Line Treatment of BRCA non-mutated Advanced Epithelial Ovarian Cancer (MK7339-001)
Study of Chemotherapy With or Without Pembrolizumab Followed by Maintenance With Olaparib or Placebo for the First-Line Treatment of BRCA non-mutated Advanced Epithelial Ovarian Cancer (MK7339-001)
Trial Category:
Gynecologic
Phase
III
Contact(s)
Location(s)
Methodist Estabrook Cancer Center, Omaha, NE
